Julian Chandler

Statistics

Publications

Citations

162

H-Index

Active since

2008

Affiliations

Alexion Pharmaceuticals (United States)(Current)

Julian Chandler is an author at Alexion Pharmaceuticals (United States) specializing in life sciences, dna replication control, and antibody discovery.

Publications per year

2008–2023

Publications

Abstract 44: The discovery of ARV-471, an orally bioavailable estrogen receptor degrading PROTAC for the treatment of patients with breast cancer

Lawrence B. Snyder, John J. Flanagan, Yimin Qian et al. · Cancer Research · 2021 · 110 citations

Life Sciences, Biochemistry, Endocrinology +15

Stem-Loop Silencing Reveals that a Third Mitochondrial DNA Polymerase, POLID, Is Required for Kinetoplast DNA Replication in Trypanosomes

Julian Chandler, Anthula V. Vandoros, Brian Mozeleski et al. · Eukaryotic Cell · 2008 · 33 citations · Full text

Life Sciences, Biology, Molecular Biology +17

Characterization of the bispecific VHH antibody gefurulimab (ALXN1720) targeting complement component 5, and designed for low volume subcutaneous administration

Siddharth Jindal, Dennis Pedersen, Nimish Gera et al. · Molecular Immunology · 2023 · 19 citations · Full text

Pharmacy, Immunology, Pharmacology +17

1–3 of 3